HOUSTON, Jan. 04, 2018 -- Most birthmarks, including Becker’s Nevus and Nevus of Ota, do not pose a threat to one’s health, explains Houston dermatologist Paul M. Friedman, MD. However, he says that these marks may produce feelings of self-consciousness if they are particularly large, grow hair, or are located in a highly visible region of the body. As a result, many patients seek treatments that can reduce the unsightly appearance of these conditions, and there are several innovative laser technologies available.
|
|||||
The first step toward treatment, Dr. Friedman explains, is to identify the birthmark with an accurate diagnosis of the skin condition, including whether the mark was congenital (present at birth or a young age) or acquired (developed after puberty). This is important, he notes, because in the case of Nevus of Ota, acquisition after puberty increases the risk of post-inflammatory hyperpigmentation following treatment. After diagnosis by a board-certified dermatologist, he explains that the physician should then develop a customized treatment plan that addresses the cosmetic goals and anatomic needs of the patient. He reveals that some of the best modalities for treating Becker’s Nevus and Nevus of Ota birthmarks are Q-switched lasers, and there are several available from which to choose.
Employing a combination of laser techniques may further optimize results, the Houston dermatologist states. “Becker’s Nevus is most commonly associated with increased hair growth of the area. We are seeing the best results by combining laser treatments to remove the hair and treat the pigmentation.” Dr. Friedman also indicates that patients should be advised to wear sun protection prior to and following laser treatment. Ultimately, the dermatologist believes that patients experiencing feelings of embarrassment due to the appearance of birthmarks, such as Becker’s Nevus and Nevus of Ota, should not have to suffer when many effective treatments are available. He encourages individuals bothered by this skin condition to schedule a consultation with a qualified dermatologist who can help them achieve their goals.
About Paul M. Friedman, MD
Certified by the American Board of Dermatology, Dr. Friedman is the Director of the Dermatology & Laser Surgery Center of Houston, Texas. A graduate of New York University School of Medicine, he also completed a fellowship in Mohs micrographic surgery, dermatologic laser surgery, and cutaneous oncology at the Laser & Skin Surgery Center of New York. In addition to his practice responsibilities, he serves at the University of Texas Medical School and the Weill Cornell Medical College as a Clinical Assistant Professor. Dr. Friedman has published over 95 medical articles and book chapters, and co-authored the book, Beautiful Skin Revealed: The Ultimate Guide to Better Skin. He is Co-Editor of the textbook Lasers and Light Source Treatment for the Skin, which was released in 2014. He also serves on the Editorial Board of the journal Dermatologic Surgery. Dr. Friedman has been recognized as a leading physician and researcher in the field and has also been involved in the development of several new laser systems and therapeutic techniques now commonly used throughout the world. He is available for interview upon request.
To view the original source of this press release, click here: https://www.dermlasersurgery.com/news-room/houston-dermatologist-reveals-laser-treatment-options-for-birthmarks/
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/e647b1ca-dfde-4371-8db4-605ea437af25
Contact: Dermatology & Laser Surgery Center Houston Office: Memorial Hermann Medical Plaza 6400 Fannin St., Ste. 2720 Houston, TX 77030 (713) 900-3900 New York Office: 317 E. 34th St. New York City, NY 10016 (917) 745-5029 Rosemont Media (858) 200-0044 www.rosemontmedia.com


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



